As another poster mentioned the other day it would be well worth...

As another poster mentioned the other day it would be well worth monitoring the market cap of this stock relative to its pre-covid level - the last 3B I could find before the pandemic was Feb 1 2019 - it had number of quoted shares + unlisted at 140,748,001. The stock price on 1 Feb 2019 was $11.67 - but even if we take the high of $17, the highest market cap it had was close to $2.4bln. This is the reason why the stock is still so heavily shorted - it's only trading at about a 33% discount to its all-time high during a time when there was no pandemic and economies all going well. Don't be fooled by the 'cheap' stock price - the dilution was massive and arguably distorting how expensive this company still is. Given revenues in calendar 2021 are going to be minimal, international borders not opened for several more months, at best, and the stock only trading at a small discount to its all-time high (given the catastrophe the company finds itself in), it's likely there's more pain in this stock before it heads upwards materially.